US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.960
  • +0.115+2.99%
Close Nov 1 16:00 ET
  • 3.980
  • +0.020+0.51%
Post 20:01 ET
747.58MMarket Cap-8800P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-62.89%1.73M
-77.09%1.53M
-53.51%18.14M
-65.65%2.15M
-21.74%4.66M
-67.34%4.65M
-46.85%6.69M
255.11%39.02M
94.79%6.25M
78.20%5.95M
Operating revenue
-62.89%1.73M
-77.09%1.53M
-53.51%18.14M
-65.65%2.15M
-21.74%4.66M
-67.34%4.65M
-46.85%6.69M
255.11%39.02M
94.79%6.25M
78.20%5.95M
Cost of revenue
Gross profit
Operating expense
-2.42%23.1M
-13.06%20.72M
-5.93%96.18M
-16.67%22.67M
10.46%26.01M
-15.88%23.67M
2.03%23.83M
23.72%102.24M
14.23%27.2M
12.71%23.55M
Selling and administrative expenses
26.20%7.55M
-4.32%5.31M
26.02%22.48M
20.05%5.1M
67.25%5.84M
15.00%5.98M
13.49%5.55M
4.07%17.83M
-7.57%4.25M
-16.50%3.49M
-General and administrative expense
26.20%7.55M
-4.32%5.31M
26.02%22.48M
20.05%5.1M
67.25%5.84M
15.00%5.98M
13.49%5.55M
4.07%17.83M
-7.57%4.25M
-16.50%3.49M
Research and development costs
-12.10%15.55M
-15.72%15.4M
-12.69%73.7M
-23.47%17.56M
0.57%20.17M
-22.88%17.69M
-1.01%18.28M
28.86%84.41M
19.45%22.95M
20.03%20.06M
Operating profit
-12.36%-21.37M
-11.92%-19.18M
-23.43%-78.03M
2.07%-20.52M
-21.35%-21.35M
-36.83%-19.02M
-59.10%-17.14M
11.76%-63.22M
-1.70%-20.95M
-0.25%-17.6M
Net non-operating interest income expense
39.15%1.8M
40.28%1.5M
1,022.10%5.23M
124.13%1.42M
446.42%1.45M
1,600.00%1.29M
408.36%1.07M
117.07%466K
219.62%634K
136.05%265K
Non-operating interest income
25.19%1.83M
21.85%1.55M
159.49%5.69M
55.36%1.47M
115.27%1.49M
268.94%1.46M
697.48%1.27M
1,625.98%2.19M
3,043.33%943K
2,470.37%694K
Non-operating interest expense
-80.12%34K
-77.78%44K
-73.41%459K
-85.76%44K
-89.28%46K
-64.52%171K
-60.87%198K
-39.59%1.73M
-44.82%309K
-43.70%429K
Other net income (expense)
-134.38%-219K
28.25%-193K
98.05%-44K
86.79%-213K
15.68%-199K
410.73%637K
-33.83%-269K
-20.78%-2.26M
-757.98%-1.61M
72.90%-236K
Gain on sale of security
-900.00%-8K
-425.00%-13K
213.64%25K
450.00%14K
128.57%6K
-66.67%1K
--4K
-540.00%-22K
---4K
-40.00%-21K
Special income (charges)
-133.18%-211K
34.07%-180K
96.91%-69K
85.89%-227K
4.65%-205K
405.77%636K
-35.82%-273K
-19.28%-2.23M
-733.68%-1.61M
74.88%-215K
-Less：Restructuring and merger&acquisition
133.18%211K
-34.07%180K
-96.91%69K
-85.89%227K
-4.65%205K
-405.77%-636K
35.82%273K
19.28%2.23M
733.68%1.61M
-74.88%215K
Income before tax
-15.81%-19.8M
-9.40%-17.88M
-12.05%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-44.32%-16.34M
14.74%-65.01M
-2.87%-21.93M
8.30%-17.57M
Income tax
0
0
0
4.44M
0
0
Net income
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
8.91%-69.46M
-2.87%-21.93M
8.30%-17.57M
Net income continuous Operations
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
8.91%-69.46M
-2.87%-21.93M
8.30%-17.57M
Minority interest income
Net income attributable to the parent company
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
8.91%-69.46M
-2.87%-21.93M
8.30%-17.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.81%-19.8M
-9.40%-17.88M
-4.89%-72.85M
11.95%-19.31M
-14.44%-20.1M
-20.45%-17.09M
-3.64%-16.34M
21.42%-69.46M
-0.17%-21.93M
27.54%-17.57M
Basic earnings per share
-10.00%-0.11
0.00%-0.1
4.35%-0.44
14.29%-0.12
0.00%-0.12
0.00%-0.1
9.09%-0.1
44.58%-0.46
6.67%-0.14
50.00%-0.12
Diluted earnings per share
-10.00%-0.11
0.00%-0.1
4.35%-0.44
14.29%-0.12
0.00%-0.12
0.00%-0.1
9.09%-0.1
44.58%-0.46
6.67%-0.14
50.00%-0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -62.89%1.73M-77.09%1.53M-53.51%18.14M-65.65%2.15M-21.74%4.66M-67.34%4.65M-46.85%6.69M255.11%39.02M94.79%6.25M78.20%5.95M
Operating revenue -62.89%1.73M-77.09%1.53M-53.51%18.14M-65.65%2.15M-21.74%4.66M-67.34%4.65M-46.85%6.69M255.11%39.02M94.79%6.25M78.20%5.95M
Cost of revenue
Gross profit
Operating expense -2.42%23.1M-13.06%20.72M-5.93%96.18M-16.67%22.67M10.46%26.01M-15.88%23.67M2.03%23.83M23.72%102.24M14.23%27.2M12.71%23.55M
Selling and administrative expenses 26.20%7.55M-4.32%5.31M26.02%22.48M20.05%5.1M67.25%5.84M15.00%5.98M13.49%5.55M4.07%17.83M-7.57%4.25M-16.50%3.49M
-General and administrative expense 26.20%7.55M-4.32%5.31M26.02%22.48M20.05%5.1M67.25%5.84M15.00%5.98M13.49%5.55M4.07%17.83M-7.57%4.25M-16.50%3.49M
Research and development costs -12.10%15.55M-15.72%15.4M-12.69%73.7M-23.47%17.56M0.57%20.17M-22.88%17.69M-1.01%18.28M28.86%84.41M19.45%22.95M20.03%20.06M
Operating profit -12.36%-21.37M-11.92%-19.18M-23.43%-78.03M2.07%-20.52M-21.35%-21.35M-36.83%-19.02M-59.10%-17.14M11.76%-63.22M-1.70%-20.95M-0.25%-17.6M
Net non-operating interest income expense 39.15%1.8M40.28%1.5M1,022.10%5.23M124.13%1.42M446.42%1.45M1,600.00%1.29M408.36%1.07M117.07%466K219.62%634K136.05%265K
Non-operating interest income 25.19%1.83M21.85%1.55M159.49%5.69M55.36%1.47M115.27%1.49M268.94%1.46M697.48%1.27M1,625.98%2.19M3,043.33%943K2,470.37%694K
Non-operating interest expense -80.12%34K-77.78%44K-73.41%459K-85.76%44K-89.28%46K-64.52%171K-60.87%198K-39.59%1.73M-44.82%309K-43.70%429K
Other net income (expense) -134.38%-219K28.25%-193K98.05%-44K86.79%-213K15.68%-199K410.73%637K-33.83%-269K-20.78%-2.26M-757.98%-1.61M72.90%-236K
Gain on sale of security -900.00%-8K-425.00%-13K213.64%25K450.00%14K128.57%6K-66.67%1K--4K-540.00%-22K---4K-40.00%-21K
Special income (charges) -133.18%-211K34.07%-180K96.91%-69K85.89%-227K4.65%-205K405.77%636K-35.82%-273K-19.28%-2.23M-733.68%-1.61M74.88%-215K
-Less：Restructuring and merger&acquisition 133.18%211K-34.07%180K-96.91%69K-85.89%227K-4.65%205K-405.77%-636K35.82%273K19.28%2.23M733.68%1.61M-74.88%215K
Income before tax -15.81%-19.8M-9.40%-17.88M-12.05%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-44.32%-16.34M14.74%-65.01M-2.87%-21.93M8.30%-17.57M
Income tax 0004.44M00
Net income -15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M8.91%-69.46M-2.87%-21.93M8.30%-17.57M
Net income continuous Operations -15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M8.91%-69.46M-2.87%-21.93M8.30%-17.57M
Minority interest income
Net income attributable to the parent company -15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M8.91%-69.46M-2.87%-21.93M8.30%-17.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.81%-19.8M-9.40%-17.88M-4.89%-72.85M11.95%-19.31M-14.44%-20.1M-20.45%-17.09M-3.64%-16.34M21.42%-69.46M-0.17%-21.93M27.54%-17.57M
Basic earnings per share -10.00%-0.110.00%-0.14.35%-0.4414.29%-0.120.00%-0.120.00%-0.19.09%-0.144.58%-0.466.67%-0.1450.00%-0.12
Diluted earnings per share -10.00%-0.110.00%-0.14.35%-0.4414.29%-0.120.00%-0.120.00%-0.19.09%-0.144.58%-0.466.67%-0.1450.00%-0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data